Daehan New Pharm Co., Ltd. (KOSDAQ: 054670)

Market Cap	99.51B
Revenue (ttm)	54.48B
Net Income (ttm)	-4.00B
Shares Out	14.04M
EPS (ttm)	-285.93
PE Ratio	n/a
Forward PE	n/a
Dividend	100.00 (1.40%)
Ex-Dividend Date	n/a

Volume	34,389
Open	7,060.00
Previous Close	7,120.00
Day's Range	7,030.00 - 7,170.00
52-Week Range	6,850.00 - 11,700.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Daehan New Pharm

Daehan New Pharm Co., Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers human medicine products, such as circulatory and endocrine system drugs; animal medicines; biopharmaceuticals, including biomedicine serums; export medicine which comprises of antibiotics, antineoplastics, and others; health functional food, as well as vitamins; and beauty and medical devices. The company was formerly known as Daehan Shinyak Co., Ltd. and changed its name to Daehan New Pharm Co., Ltd in April 2...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 228
• Stock Exchange: KOSDAQ
• Ticker Symbol: 054670